This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the editor after publication concerns were raised with respect to data presented in Figure 2. The journal contacted Southern Medical University, Guangzhou, Guangdong Province, China, who formed an Academic Committee to investigate. According to the “Academic Ethics and Implementation Rules” of Southern Medical University, the Committee reported evidence of improper preservation of original data and incorrect use of pictures, and recommended immediate withdrawal of the paper. Specifically, in the PC-3 group of Fig. 2H, the ‘Control’ cell migration image had been partially duplicated in the ‘Empty vector’ image. As per journal policy, original files used to create the entire figure were requested. Raw western blot images were not available for Figure 2 C+F, and experimental repeats yielded protein level discrepancies with the original published data. The editors therefore no longer have confidence in the integrity of these data.
. 2021 Oct 27;72:103665. doi: 10.1016/j.ebiom.2021.103665
Retraction notice to "LSAMP-AS1 binds to microRNA-183–5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190]
Xing Hua
a, Zhen Liu
b, Min Zhou
c, Yan Tian
d,e,f, Pei-Pei Zhao
d,e,f, Wen-Hai Pan
a, Chao-Xia Li
a, Xiao-Xiao Huang
a, Ze-Xiao Liao
a, Qi Xian
a, Bo Chen
a, Yue Hu
a, Lei Leng
a, Xiao-Wei Fang
a, Li-Na Yu
d,e,f
Xing Hua
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Xing Hua
Zhen Liu
bDepartment of Pathology, School of Basic Medical
Sciences, Guizhou Medical University, Guiyang 550025, P.R. China
Find articles by Zhen Liu
Min Zhou
cDepartment of Otolaryngology, The First Affiliated
Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, P.R.
China
Find articles by Min Zhou
Yan Tian
dDepartment of pathology, School of Basic Medical
Sciences, Southern Medical University, Guanghou 510515, P.R.China
eDepartment of pathology, Nanfang Hospital, Guanghou
510515, P.R. China
fGuangdong Provincial Key Laboratory of Molecular Tumor
Pathology, Guangzhou 510515, P.R. China
Find articles by Yan Tian
Pei-Pei Zhao
dDepartment of pathology, School of Basic Medical
Sciences, Southern Medical University, Guanghou 510515, P.R.China
eDepartment of pathology, Nanfang Hospital, Guanghou
510515, P.R. China
fGuangdong Provincial Key Laboratory of Molecular Tumor
Pathology, Guangzhou 510515, P.R. China
Find articles by Pei-Pei Zhao
Wen-Hai Pan
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Wen-Hai Pan
Chao-Xia Li
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Chao-Xia Li
Xiao-Xiao Huang
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Xiao-Xiao Huang
Ze-Xiao Liao
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Ze-Xiao Liao
Qi Xian
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Qi Xian
Bo Chen
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Bo Chen
Yue Hu
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Yue Hu
Lei Leng
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Lei Leng
Xiao-Wei Fang
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
Find articles by Xiao-Wei Fang
Li-Na Yu
dDepartment of pathology, School of Basic Medical
Sciences, Southern Medical University, Guanghou 510515, P.R.China
eDepartment of pathology, Nanfang Hospital, Guanghou
510515, P.R. China
fGuangdong Provincial Key Laboratory of Molecular Tumor
Pathology, Guangzhou 510515, P.R. China
Find articles by Li-Na Yu
aDepartments of Pathology, Guangzhou Red Cross Hospital,
Medical College, Jinan University, Guangzhou 510220, P.R. China
bDepartment of Pathology, School of Basic Medical
Sciences, Guizhou Medical University, Guiyang 550025, P.R. China
cDepartment of Otolaryngology, The First Affiliated
Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, P.R.
China
dDepartment of pathology, School of Basic Medical
Sciences, Southern Medical University, Guanghou 510515, P.R.China
eDepartment of pathology, Nanfang Hospital, Guanghou
510515, P.R. China
fGuangdong Provincial Key Laboratory of Molecular Tumor
Pathology, Guangzhou 510515, P.R. China
Collection date 2021 Oct.
© 2019 The Authors
PMCID: PMC8577328 PMID: 34717838
This retracts the article "LSAMP-AS1 binds to microRNA-183–5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" in volume 50 on page 178.